Evaluation of a Cyanoacrylate Dressing to Manage Peristomal Skin Alterations Under Ostomy Skin Barrier Wafers

Evaluation of a Cyanoacrylate Dressing to Manage Peristomal Skin Alterations Under Ostomy Skin Barrier Wafers
复制标题

氰基丙烯酸酯敷料管理造口皮肤屏障片下造口周围皮肤变化的评估

DOI:
10.1097/won.0b013e318234550a
复制
发表时间:
2011
期刊:
Journal of Wound, Ostomy and Continence Nursing
影响因子:
--
通讯作者:
Juliet Smith
Juliet Smith
中科院分区:
--
文献类型:
--
作者:
C. Milne;D. Saucier;Chenel Trevellini;Juliet Smith

文献摘要

被引文献

相似文献

背景:造口屏障下的口周皮肤改变是一个常见的问题。虽然已经报道了一些处理这一问题的干预措施,但使用局部应用的氰基丙烯酸酯却很少受到关注。本病例系列描述了使用局部氰基丙烯酸酯治疗造口术患者的口周皮肤改变。案例介绍:使用方便的样品,局部氰基丙烯酸酯敷料应用于11例患者在急性护理和门诊设置造口术下的口周皮肤破裂。屏障功能中断的原因也被解决,以提高结果。使用李克特量表评估患者的伤口不适、愈合时间和器械更换次数。患者满意度也被检查。结论:在首次肠周刺激评估访问时,报告的平均不适程度为9.5(满分10分),在第一次更换硅片时下降到3.5,在第二次更换硅片时消失。在两种情况下,晶圆片的磨损时间增加,急性护理患者的反应更快。表皮重塑在门诊患者的10.2天内发生,在急性护理患者的7天内发生。由于这种敷料的皮肤密封作用,在所有眼袋变化中立即粘附晶圆片。
BACKGROUND: Peristomal skin alterations under ostomy barrier wafers are a commonly reported problem. While a number of interventions to manage this issue have been reported, the use of a topically applied cyanoacrylate has received little attention. This case series describes the use of a topical cyanoacrylate for the management of peristomal skin alterations in persons living with an ostomy. CASE PRESENTATIONS: Using a convenience sample, the topical cyanoacrylate dressing was applied to 11 patients with peristomal skin disruption under ostomy wafers in acute care and outpatient settings. The causes of barrier function interruption were also addressed to enhance outcomes. Patients were assessed for wound discomfort using a Likert Scale, time to healing, and number of appliance changes. Patient satisfaction was also examined. CONCLUSION: Average reported discomfort levels were 9.5 out of 10 at the initial peristomal irritation assessment visit decreased to 3.5 at the first wafer change and were absent by the second wafer change. Wafers had increasing wear time between changes in both settings with acute care patients responding faster. Epidermal resurfacing occurred within 10.2 days in outpatients and within 7 days in acute care patients. Because of the skin sealant action of this dressing, immediate adherence of the wafer was reported at all pouch changes.